Crotoxin induces apoptosis and autophagy in human lung carcinoma cells in vitro via activation of the p38 MAPK signaling pathway

被引:36
作者
Han, Rong [1 ]
Liang, Hui [1 ]
Qin, Zheng-hong [1 ]
Liu, Chun-yu [1 ]
机构
[1] Soochow Univ, Coll Pharmaceut Sci, Suzhou 215123, Peoples R China
关键词
human lung carcinoma; snake venom; crotoxin; cell cycle arrest; apoptosis; autophagy; caspase-3; proliferating cell nuclear antigen; p38; MAPK; SB203580; ANTITUMOR-ACTIVITY; INDUCTION; ANTIBODY; COMPLEX; DEATH; VENOM; CRTX; JNK;
D O I
10.1038/aps.2014.62
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Aim: Crotoxin (CrTX) is the primary toxin in South American rattlesnake (Crotalus durissus terrificus) venom, and exhibits antitumor and other pharmacological actions in vivo and in vitro. Here, we investigated the molecular mechanisms of the antitumor action of CrTX in human lung carcinoma cells in vitro. Methods: Human lung squamous carcinoma SK-MES-1 cells were tested. The cytotoxicity of CrTX was evaluated in both MIT and colony formation assays. Cell cycle was investigated with flow cytometry. Cell apoptosis was studied with Hoechst 33258 and Annexin V-FITC staining. The levels of relevant proteins were analyzed using Western blot assays. Results: CrTX (25, 50, 100 mu mol/L) inhibited the growth and colony formation of SK-MES-1 cells in dose- and time-dependent manners. CrTX increased the proportion of S phase cells and dose-dependently induced cell apoqtosis, accompanied by down-regulating the expression of proliferating cell nuclear antigen (PCNA), and increasing the level of cleaved caspase-3. Furthermore, CrTX dose-dependently increased the expression of autophagy-related proteins LC3-II and beclin 1, and decreased the level of p62 in the cells. Moreover, CrTX (50 mu mol/L) significantly increased p38MAPK phosphorylation in the cells. Pretreatment of the cells with SB203580, a specific inhibitor of p38MAPK, blocked the inhibition of CrTX on cell proliferation, as well as CrTX-induced apoptosis and cleaved caspase-3 expression. Conclusion: The p38MAPK signaling pathway mediates CrTX-induced apoptosis and autophagy of human lung carcinoma SK-MES-1 cells in vitro.
引用
收藏
页码:1323 / 1332
页数:10
相关论文
共 36 条
[1]   Relationship between the structure and the enzymatic activity of crotoxin complex and its phospholipase A2 subunit: An in silico approach [J].
Andres Pereanez, Jaime ;
Dario Gomez, Ivan ;
Camilo Patino, Arley .
JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2012, 35 :36-42
[2]  
BALDI A, 1988, MEDICINA-BUENOS AIRE, V48, P337
[3]   MONITORING AUTOPHAGIC DEGRADATION OF P62/SQSTM1 [J].
Bjorkoy, Geir ;
Lamark, Trond ;
Pankiv, Serhiy ;
Overvatn, Aud ;
Brech, Andreas ;
Johansen, Terje .
METHODS IN ENZYMOLOGY: AUTOPHAGY IN MAMMALIAN SYSTEMS, VOL 452, PT B, 2009, 452 :181-197
[4]   p38 MAPK in development and cancer [J].
Bradham, Cynthia ;
McClay, David R. .
CELL CYCLE, 2006, 5 (08) :824-828
[5]   Autophagy, Apoptosis, Mitoptosis and Necrosis: Interdependence Between Those Pathways and Effects on Cancer [J].
Chaabane, Wiem ;
User, Sirma D. ;
El-Gazzah, Mohamed ;
Jaksik, Roman ;
Sajjadi, Elaheh ;
Rzeszowska-Wolny, Joanna ;
Los, Marek J. .
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2013, 61 (01) :43-58
[6]   Autophagy Induction by Capsaicin in Malignant Human Breast Cells Is Modulated by p38 and Extracellular Signal-Regulated Mitogen-Activated Protein Kinases and Retards Cell Death by Suppressing Endoplasmic Reticulum Stress-Mediated Apoptosis [J].
Choi, Cheol-Hee ;
Jung, Yong-Keun ;
Oh, Seon-Hee .
MOLECULAR PHARMACOLOGY, 2010, 78 (01) :114-125
[7]   Autophagy and cancer [J].
Choi, Kyeong Sook .
EXPERIMENTAL AND MOLECULAR MEDICINE, 2012, 44 (02) :109-120
[8]   CYTOTOXICITY OF CROTOXIN ON MURINE ERYTHROLEUKEMIA-CELLS INVITRO [J].
CORIN, RE ;
VISKATIS, LJ ;
VIDAL, JC ;
ETCHEVERRY, MA .
INVESTIGATIONAL NEW DRUGS, 1993, 11 (01) :11-15
[9]  
Cura JE, 2002, CLIN CANCER RES, V8, P1033
[10]   RETRACTED: P38MAPK is a major determinant of the balance between apoptosis and autophagy triggered by 5-fluorouracil: implication in resistance (Retracted Article) [J].
de la Cruz-Morcillo, M. A. ;
Valero, M. L. L. ;
Callejas-Valera, J. L. ;
Arias-Gonzalez, L. ;
Melgar-Rojas, P. ;
Galan-Moya, E. M. ;
Garcia-Gil, E. ;
Garcia-Cano, J. ;
Sanchez-Prieto, R. .
ONCOGENE, 2012, 31 (09) :1073-1085